IP Library › Granted Patent US 12,661,490
Granted Patent B2
US 12,661,490 · App. 17/889,423 · Granted Jun 23, 2026

Devices for shunting blood

Inventor: Stefan Schreck (Duvall, WA)
Assignee: Inspire M.D Ltd.
A61M39/0613A61M29/02A61M39/0208A61M39/1011A61M2029/025A61M2039/0241A61M2039/0258A61M2039/062
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,661,490
App. No.
17/889,423
Filed
Aug 17, 2022
Granted
Jun 23, 2026
Kind
B2
Art Unit
3781
USPC
604/6.1
Abstract

An apparatus includes a hub including a front port, a side port, and a back port including a hemostasis valve. The apparatus further includes a sheath extending from the hemostasis valve through the front port and shaped to define one or more lateral openings within the hub. The sheath is configured for insertion into a blood vessel such that, subsequently to the insertion, a rate of flow of blood between the side port and the blood vessel via the lateral openings is controllable using an instrument passing through the hemostasis valve and into the sheath such that the instrument closes at least a portion of the lateral openings. Other embodiments are also described.

Claims (44)

1 . An apparatus, comprising:

a hub comprising a front port, a side port, and a back port comprising a hemostasis valve;

a sheath extending from the hemostasis valve through the front port and shaped to define one or more lateral openings within the hub,

the sheath being configured for insertion into a blood vessel; and

an instrument configured to reduce a rate of flow of blood between the side port and the blood vessel via the lateral openings without stopping the flow, subsequently to the insertion, by passing through the hemostasis valve and into the sheath such that the instrument closes at least a portion of the lateral openings.

2 . The apparatus according to claim 1 , wherein a cross-sectional area of a lumen of the side port is at least 3.8 mm 2 .

3 . The apparatus according to claim 1 , wherein a total area of the lateral openings is at least as large as an area of the side port.

4 . The apparatus according to claim 1 , wherein the sheath comprises:

a back sheath, which is disposed within the hub and is shaped to define the lateral openings; and

a front sheath, which is connected to the back sheath and is configured for insertion into the blood vessel.

5 . The apparatus according to claim 1 , wherein the sheath is connected to the back port.

6 . The apparatus according to claim 1 , further comprising a tube configured to connect to the side port.

7 . The apparatus according to claim 1 , wherein the instrument comprises a dilator configured to facilitate the insertion by dilating the blood vessel.

8 . The apparatus according to claim 1 , wherein the openings are arranged in one or more rows.

9 . The apparatus according to claim 1 , wherein the openings include one or more slots.

10 . The apparatus according to claim 1 , further comprising a blood filter disposed between the lateral openings and the side port such that the blood flows through the blood filter.

11 . The apparatus according to claim 1 , wherein the apparatus is for use with another hub including another front port, which is connected to another sheath, and another back port, which includes another hemostasis valve, and wherein the apparatus further comprises:

a tube configured to connect to the side port; and

an adapter configured to connect to the tube and configured for insertion through the other hemostasis valve such that, subsequently to an insertion of the other sheath into another blood vessel, the blood flows between the other blood vessel and the tube via the adapter.

12 . The apparatus according to claim 11 , wherein the adapter comprises one or more barbs configured to inhibit the adapter from exiting the other hub subsequently to the insertion of the adapter.

13 . The apparatus according to claim 11 , wherein the adapter comprises:

a straight connector, comprising:

a front end, configured for insertion through the other hemostasis valve; and

a back end; and

a tube connector, which comprises a front connector port connected to the back end of the straight connector and is configured to connect to the tube.

14 . The apparatus according to claim 13 , wherein the tube connector further comprises a back connector port configured to connect to the tube.

15 . The apparatus according to claim 13 , wherein the other hemostasis valve is a first other hemostasis valve, and wherein the tube connector further comprises:

a back connector port, comprising a second other hemostasis valve; and

one or more side connector ports, at least one of which is configured to connect to the tube.

16 . The apparatus according to claim 13 , wherein the tube connector comprises a T-connector.

17 . The apparatus according to claim 13 , wherein the tube connector comprises a Y-connector.

18 . The apparatus according to claim 1 , further comprising:

another sheath;

another hub, comprising another front port, which is connected to the other sheath, and another back port comprising another hemostasis valve;

an adapter passing through the other hemostasis valve; and

a tube configured to connect to the side port and connected to the adapter such that, subsequently to an insertion of the other sheath into another blood vessel, the blood flows between the other blood vessel and the tube via the adapter.

19 . The apparatus according to claim 1 , wherein the instrument comprises multiple markings configured to indicate different respective sizes of the portion of the lateral openings that is closed by the instrument, by virtue of the markings progressively entering the hub as the instrument is pushed through the hemostasis valve.

20 . A method, comprising:

inserting a sheath, which extends from a hemostasis valve at a back port of a hub through a front port of the hub, into a blood vessel, the sheath being shaped to define one or more lateral openings within the hub; and

subsequently to inserting the sheath, passing an instrument through the hemostasis valve and into the sheath, and using the instrument to close at least a portion of the lateral openings so as to control a rate of flow of blood between a side port of the hub and the blood vessel via the lateral openings.

21 . The method according to claim 20 , further comprising:

inserting an adapter, which is connected to a tube connected to the side port, through another hemostasis valve at another back port of another hub; and

inserting another sheath, which is connected to another front port of the other hub, into another blood vessel such that the blood flows between the other blood vessel and the tube via the adapter.

22 . The method according to claim 20 , wherein using the instrument comprises using the instrument to reduce the rate without stopping the flow, by closing the portion of the lateral openings.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2022
From: SCHRECK, STEFAN
To: INSPIRE M.D LTD.
Reel/Frame 060838/0741 →
Continuity (1)
Related Publication 20240058591A1 · Feb 22, 2024
References Cited (281)
US 3641994A · Gosling et al. · 1972 [cited by applicant]
US 3889687A · Harris et al. · 1975 [cited by applicant]
US 4559034A · Kirita et al. · 1985 [cited by applicant]
US 4661097A · Fischell et al. · 1987 [cited by applicant]
US 4874359A · White et al. · 1989 [cited by applicant]
US 5334163A · Sinnett · 1994 [cited by applicant]
US 5374239A · Mischenko · 1994 [cited by applicant]
US 5395105A · Thommen, Jr. · 1995 [cited by applicant]
US 5437290A · Bolger et al. · 1995 [cited by applicant]
US 5601572A · Middleman et al. · 1997 [cited by applicant]
US 5843244A · Pelton et al. · 1998 [cited by applicant]
US 5954691A · Prosl · 1999 [cited by applicant]
US 6019772A · Shefaram et al. · 2000 [cited by applicant]
US 6019778A · Wilson et al. · 2000 [cited by applicant]
US 6071269A · Schnell et al. · 2000 [cited by applicant]
US 6109406A · Takagi et al. · 2000 [cited by applicant]
US 6129755A · Mathis et al. · 2000 [cited by applicant]
US 6206868B1 · Parodi · 2001 [cited by applicant]
US 6235042B1 · Katzman · 2001 [cited by applicant]
US 6295989B1 · Connors, III · 2001 [cited by applicant]
US 6312454B1 · Stoeckel et al. · 2001 [cited by applicant]
US 6312455B2 · Duerig et al. · 2001 [cited by applicant]
US 6413235B1 · Parodi · 2002 [cited by applicant]
US 6423032B2 · Parodi · 2002 [cited by applicant]
US 6425898B1 · Wilson et al. · 2002 [cited by applicant]
US 6503271B2 · Duerig et al. · 2003 [cited by applicant]
US 6514236B1 · Stratienko · 2003 [cited by examiner]
US 6540712B1 · Parodi et al. · 2003 [cited by applicant]
US 6582396B1 · Parodi · 2003 [cited by applicant]
US 6632236B2 · Hogendijk · 2003 [cited by applicant]
US 6641573B1 · Parodi · 2003 [cited by applicant]
US 6645222B1 · Parodi et al. · 2003 [cited by applicant]
US 6682505B2 · Bates et al. · 2004 [cited by applicant]
US 6689084B2 · Kaganov et al. · 2004 [cited by applicant]
US 6726659B1 · Stocking · 2004 [cited by examiner]
US 6743219B1 · Dwyer et al. · 2004 [cited by applicant]
US 6773446B1 · Dwyer et al. · 2004 [cited by applicant]
US 6859986B2 · Jackson et al. · 2005 [cited by applicant]
US 6863685B2 · Davila et al. · 2005 [cited by applicant]
US 6905490B2 · Parodi · 2005 [cited by applicant]
US 6908474B2 · Hogendijk et al. · 2005 [cited by applicant]
US 6935404B2 · Duerig et al. · 2005 [cited by applicant]
US 6936060B2 · Hogendijk et al. · 2005 [cited by applicant]
US 6942688B2 · Bartholf et al. · 2005 [cited by applicant]
US 7063685B2 · Rome · 2006 [cited by applicant]
US 7344527B2 · Schweikert et al. · 2008 [cited by applicant]
US 7879011B2 · Chang · 2011 [cited by applicant]
US 7927347B2 · Hogendijk et al. · 2011 [cited by applicant]
US 7998104B2 · Chang · 2011 [cited by applicant]
US 8002728B2 · Chang · 2011 [cited by applicant]
US 8157760B2 · Criado et al. · 2012 [cited by applicant]
US 8235943B2 · Breznock et al. · 2012 [cited by applicant]
US 8308709B2 · Chang · 2012 [cited by applicant]
US 8343089B2 · Chang · 2013 [cited by applicant]
US 8414516B2 · Chang · 2013 [cited by applicant]
US 8444586B2 · Beck · 2013 [cited by applicant]
US 8545432B2 · Renati et al. · 2013 [cited by applicant]
US 8545552B2 · Garrison et al. · 2013 [cited by applicant]
US 8574245B2 · Garrison et al. · 2013 [cited by applicant]
US 8740834B2 · Criado et al. · 2014 [cited by applicant]
US 8784355B2 · Criado et al. · 2014 [cited by applicant]
US 8858490B2 · Chou et al. · 2014 [cited by applicant]
US 8870805B2 · Chang · 2014 [cited by applicant]
US 9011364B2 · Criado et al. · 2015 [cited by applicant]
US 9011467B2 · Garrison et al. · 2015 [cited by applicant]
US 9084857B2 · Cully et al. · 2015 [cited by applicant]
US 9126018B1 · Garrison · 2015 [cited by applicant]
US 9138527B2 · Renati et al. · 2015 [cited by applicant]
US 9179909B2 · Garrison et al. · 2015 [cited by applicant]
US 9241699B1 · Kume et al. · 2016 [cited by applicant]
US 9259215B2 · Chou et al. · 2016 [cited by applicant]
US 9265512B2 · Garrison et al. · 2016 [cited by applicant]
US 9295817B2 · Chang · 2016 [cited by applicant]
US 9399118B2 · Kume et al. · 2016 [cited by applicant]
US 9427305B2 · Kuraguntla et al. · 2016 [cited by applicant]
US 9492637B2 · Garrison et al. · 2016 [cited by applicant]
US 9526504B2 · Chang · 2016 [cited by applicant]
US 9561345B2 · Garrison et al. · 2017 [cited by applicant]
US 9623228B2 · Ryan et al. · 2017 [cited by applicant]
US 9655755B2 · Chou et al. · 2017 [cited by applicant]
US 9662118B2 · Chang · 2017 [cited by applicant]
US 9662480B2 · Kume et al. · 2017 [cited by applicant]
US 9668743B2 · Cully et al. · 2017 [cited by applicant]
US 9669183B2 · Chang · 2017 [cited by applicant]
US 9669191B2 · Chou et al. · 2017 [cited by applicant]
US 9693789B2 · Garrison et al. · 2017 [cited by applicant]
US 9789242B2 · Criado et al. · 2017 [cited by applicant]
US 9820761B2 · Garrison et al. · 2017 [cited by applicant]
US 9833555B2 · Criado et al. · 2017 [cited by applicant]
US 9861783B2 · Garrison et al. · 2018 [cited by applicant]
US 10039906B2 · Kume et al. · 2018 [cited by applicant]
US 10085864B2 · Chou et al. · 2018 [cited by applicant]
US 10159479B2 · Hentges et al. · 2018 [cited by applicant]
US 10182801B2 · Garrison · 2019 [cited by applicant]
US 10188399B2 · Chang · 2019 [cited by applicant]
US 10226563B2 · Garrison et al. · 2019 [cited by applicant]
US 10226598B2 · Chou et al. · 2019 [cited by applicant]
US 10238853B2 · Kume et al. · 2019 [cited by applicant]
US 10272269B2 · Garrison et al. · 2019 [cited by applicant]
US 10286139B2 · Criado et al. · 2019 [cited by applicant]
US 10327790B2 · Garrison et al. · 2019 [cited by applicant]
US 10328232B2 · Chang · 2019 [cited by applicant]
US 10357242B2 · Garrison et al. · 2019 [cited by applicant]
US 10369346B2 · Ryan et al. · 2019 [cited by applicant]
US 10384034B2 · Garrison et al. · 2019 [cited by applicant]
US 10390847B2 · Garrison et al. · 2019 [cited by applicant]
US 10426497B2 · Chou et al. · 2019 [cited by applicant]
US 10426885B2 · Criado et al. · 2019 [cited by applicant]
US 10485917B2 · Criado et al. · 2019 [cited by applicant]
US 10543307B2 · Criado et al. · 2020 [cited by applicant]
US 10709832B2 · Criado et al. · 2020 [cited by applicant]
US 10722239B2 · Chang · 2020 [cited by applicant]
US 10779835B2 · Chang · 2020 [cited by applicant]
US 10779855B2 · Garrison · 2020 [cited by applicant]
US 10799244B2 · Cully et al. · 2020 [cited by applicant]
US 10799669B2 · Chou et al. · 2020 [cited by applicant]
US 10828460B2 · Chang · 2020 [cited by applicant]
US 10864357B2 · Kume et al. · 2020 [cited by applicant]
US 10881393B2 · Hentges et al. · 2021 [cited by applicant]
US 10918504B2 · Wallace et al. · 2021 [cited by applicant]
US 10925709B2 · Rogers et al. · 2021 [cited by applicant]
US 10939929B2 · Garrison et al. · 2021 [cited by applicant]
US 10952882B2 · Chou et al. · 2021 [cited by applicant]
US 10973502B2 · Garrison · 2021 [cited by applicant]
US 11020133B2 · Wilson et al. · 2021 [cited by applicant]
US 11027104B2 · Kume et al. · 2021 [cited by applicant]
US 11097132B2 · Garrison et al. · 2021 [cited by applicant]
US 11103627B2 · Garrison et al. · 2021 [cited by applicant]
US 11129965B2 · Humbert et al. · 2021 [cited by applicant]
US 11141259B2 · MacDonald et al. · 2021 [cited by applicant]
US 11364369B2 · Chou et al. · 2022 [cited by applicant]
US 11478248B2 · Sultan et al. · 2022 [cited by applicant]
US 12156960B2 · Chou et al. · 2024 [cited by applicant]
US 12156961B2 · Kume et al. · 2024 [cited by applicant]
US 20010047184A1 · Connors, III · 2001 [cited by applicant]
US 20020087119A1 · Parodi · 2002 [cited by applicant]
US 20040073243A1 · Sepetka · 2004 [cited by applicant]
US 20050113798A1 · Slater · 2005 [cited by examiner]
US 20070055296A1 · Stergiopulos · 2007 [cited by applicant]
US 20090024072A1 · Criado et al. · 2009 [cited by applicant]
US 20090048654A1 · Chmura et al. · 2009 [cited by applicant]
US 20090240235A1 · Murata · 2009 [cited by applicant]
US 20100168682A1 · Braga et al. · 2010 [cited by applicant]
US 20100198158A1 · Loewen · 2010 [cited by applicant]
US 20100204684A1 · Garrison et al. · 2010 [cited by applicant]
US 20110004147A1 · Renati et al. · 2011 [cited by applicant]
US 20110098649A1 · Nardeo et al. · 2011 [cited by applicant]
US 20110251482A1 · Kellerman et al. · 2011 [cited by applicant]
US 20110284776A1 · Gay et al. · 2011 [cited by applicant]
US 20120046515A1 · Woo et al. · 2012 [cited by applicant]
US 20130041305A1 · Tarlian, Jr. et al. · 2013 [cited by applicant]
US 20130317409A1 · Cully et al. · 2013 [cited by applicant]
US 20140031854A1 · Goode et al. · 2014 [cited by applicant]
US 20140074144A1 · Shrivastava et al. · 2014 [cited by applicant]
US 20140088482A1 · Schlaeper et al. · 2014 [cited by applicant]
US 20140221932A1 · Puhasmagi et al. · 2014 [cited by applicant]
US 20140243759A1 · Yoon et al. · 2014 [cited by applicant]
US 20140296769A1 · Hyde et al. · 2014 [cited by applicant]
US 20140303427A1 · Kerkhoffs et al. · 2014 [cited by applicant]
US 20160022292A1 · Stigall et al. · 2016 [cited by applicant]
US 20160220791A1 · Akcay · 2016 [cited by examiner]
US 20160242764A1 · Garrison et al. · 2016 [cited by applicant]
US 20160296690A1 · Kume · 2016 [cited by examiner]
US 20160317288A1 · Rogers et al. · 2016 [cited by applicant]
US 20160354082A1 · Oz et al. · 2016 [cited by applicant]
US 20170056175A1 · Chin et al. · 2017 [cited by applicant]
US 20190125512A1 · MacDonald · 2019 [cited by examiner]
US 20190328411A1 · Vale et al. · 2019 [cited by applicant]
US 20190344058A1 · Hakim · 2019 [cited by applicant]
US 20190351182A1 · Chou et al. · 2019 [cited by applicant]
US 20190358443A1 · Lopez et al. · 2019 [cited by applicant]
US 20190380563A1 · Sanghvi · 2019 [cited by examiner]
US 20200289039A1 · Bullington et al. · 2020 [cited by applicant]
US 20200289794A1 · Fantuzzi · 2020 [cited by applicant]
US 20200292367A1 · Elizalde · 2020 [cited by applicant]
US 20200397472A1 · MacDonald et al. · 2020 [cited by applicant]
US 20210001091A1 · Schmidt · 2021 [cited by examiner]
US 20210145453A1 · Kume · 2021 [cited by applicant]
US 20210298929A1 · Wallace et al. · 2021 [cited by applicant]
US 20220201081A1 · Nagamura · 2022 [cited by applicant]
US 20220226556A1 · Drake et al. · 2022 [cited by applicant]
US 20230013548A1 · Vale et al. · 2023 [cited by applicant]
US 20230097442A1 · Criado et al. · 2023 [cited by applicant]
US 20240197349A1 · Kelly et al. · 2024 [cited by applicant]
US 20240423626A1 · Chang · 2024 [cited by applicant]
US 20240424266A1 · Kume et al. · 2024 [cited by applicant]
US 20250114506A1 · Chou et al. · 2025 [cited by applicant]
US 20250114507A1 · Garrison et al. · 2025 [cited by applicant]
US 20250114586A1 · Ryan et al. · 2025 [cited by applicant]
US 20250127975A1 · Kume et al. · 2025 [cited by applicant]
AU 774994B2 · 2004 [cited by applicant]
CN 100534392C · 2009 [cited by applicant]
CN 204709643U · 2015 [cited by applicant]
CN 209848141U · 2019 [cited by applicant]
EP 2497520A1 · 2012 [cited by applicant]
EP 1356836B1 · 2013 [cited by applicant]
JP S51115963U · 1976 [cited by applicant]
JP S5542266Y2 · 1980 [cited by applicant]
JP S6025136B2 · 1985 [cited by applicant]
JP S60100958A · 1985 [cited by applicant]
JP S62501057A · 1987 [cited by applicant]
JP S6223488U · 1987 [cited by applicant]
JP H065636U · 1994 [cited by applicant]
JP H09507148A · 1997 [cited by applicant]
JP 2014526306A · 2014 [cited by applicant]
JP 2019154669A · 2019 [cited by applicant]
JP 2019524346A · 2019 [cited by applicant]
JP 2020142074A · 2020 [cited by applicant]
PT 1951362E · 2010 [cited by applicant]
RU 2759406C1 · 2021 [cited by applicant]
WO 1995018647A2 · 1995 [cited by applicant]
WO 2004011058A2 · 2004 [cited by applicant]
WO 2004058321A2 · 2004 [cited by applicant]
WO 2005051206A1 · 2005 [cited by applicant]
WO 2007078680A2 · 2007 [cited by applicant]
WO 2009012473A2 · 2009 [cited by applicant]
WO 2009100210A1 · 2009 [cited by applicant]
WO 2010075445A1 · 2010 [cited by applicant]
WO 2013008168A1 · 2013 [cited by applicant]
WO 2013022796A2 · 2013 [cited by applicant]
WO 2013036193A1 · 2013 [cited by applicant]
WO 2013130258A1 · 2013 [cited by applicant]
WO 2013181352A1 · 2013 [cited by applicant]
WO 2015100178A1 · 2015 [cited by applicant]
WO 2015134758A1 · 2015 [cited by applicant]
WO 2016018781A1 · 2016 [cited by applicant]
WO 2016036660A1 · 2016 [cited by applicant]
WO 2016164606A1 · 2016 [cited by applicant]
WO 2016176409A1 · 2016 [cited by applicant]
WO 2018017981A1 · 2018 [cited by applicant]
WO 2018156574A1 · 2018 [cited by applicant]
WO 2019010077A1 · 2019 [cited by applicant]
WO 2019055487A1 · 2019 [cited by applicant]
WO 2019173475A1 · 2019 [cited by applicant]
WO 2019183189A1 · 2019 [cited by applicant]
WO 2021007200A1 · 2021 [cited by applicant]
WO 2021087363A1 · 2021 [cited by applicant]
WO 2021087480A1 · 2021 [cited by applicant]
WO 2022201081A1 · 2022 [cited by applicant]
“International Standard, ISO 80368-7: Small-bore connectors for liquids and gases in healthcare applications—Part 7: Connectors for intravascular or hypodermic applications, Oct. 15, 2016, ISO, p. iv-11, https://simples… [cited by examiner]
Saint-Gobain Performance Plastics Corporation, “Tygon Medical/Surgical Tubing S-50-HL,” pp. 1-2, year 2004. [cited by applicant]
Silk Road Medical Inc., “Enhance Transcarotid Peripheral Access Kit,” pp. 1-2, Dec. 28, 2018. [cited by applicant]
Silk Road Medical Inc., “Enroute Transcarotid Stent System,” pp. 1-4, May 27, 2021. [cited by applicant]
Sherif, “Homemade TCAR with Flow Reversal for Primary Proximal Carotid Artery Aneurisms in a Patent with Crescendo TIAS post neck operation,” Linkedin post, pp. 1-2, year 2021, as downloaded from https://www.linkedin.co… [cited by applicant]
Silk Road Medical, Inc., “Enroute Transcarotid Neuroprotection System”, Manual, pp. 1-20, Mar. 7, 2020, year 2022, as downloaded from file:///C:/Users/Miriam/Downloads/_https__silkroadmed.com_wp-content_uploads_2020_09_… [cited by applicant]
Parodi et al., “Cerebral Protection During Carotid Stenting Using Flow Reversal,” Journal of Vascular Surgery, vol. 41, No. 3, pp. 416-422, year 2005. [cited by applicant]
Perez-Grueso et al., “Angioplastia y Stenting Carotideo por Miniacceso Cervical y Flujo Invertido,” Angiologia, vol. 56, supl. 1, pp. S225-S234, year 2004. [cited by applicant]
Luk et al., “Transcarotid Artery Revascularization as a New Modality of Treatment for Carotid Stenosis,” Journal Pre-proof, Annals of Vascular Surgery, Elsevier Inc., pp. 1-14, year 2019. [cited by applicant]
Chang et al., “A New Approach to Carotid Angioplasty and Stenting with Transcervical Occlusion and Protective Shunting: Why it May be a Better Carotid Artery Intervention,” Journal of Vascular Surgery, vol. 39, No. 5, p… [cited by applicant]
Lin et al., “Protected Carotid Artery Stenting and Angioplasty via Transfemoral versus Transcervical Approaches,” Vascular and Endovascular Surgery, vol. 39, No. 6, pp. 499-503, year 2005. [cited by applicant]
Silk Road Medical, “TransCarotid Artery Revascularization (TCAR),” Product Overview, pp. 1-6, year 2022, as downloaded from https://silkroadmed.com/patient-caregivers/the-tcar-procedure/. [cited by applicant]
Rhodes et al., “Arteriovenous Shunt Measurements in Extremities,” Journal of Nuclear Medicine, vol. 13, No. 6, pp. 357-362, year 1972. [cited by applicant]
“Qosina—Medical Device Components/OEM Components,” product catalogue, Qosina Corp., USA, Qosina Europe Srl., Italy, pp. 1-4, year 2022, as downloaded from https://www.qosina.com/. [cited by applicant]
Sherif, “The TCAR Procedure: Transcervical carotid Artery Revascularization and stenting by C-Guard”, Linkedin post, p. 1-1, year 2021, as downloaded from https://www.linkedin.com/feed/update/urn:li: activity:6689646427… [cited by applicant]
Drake et al., U.S. Appl. No. 63/211,025, filed Jun. 16, 2021. [cited by applicant]
InspireMD, “Sustained Embolic Protection”, pp. 1-23, Jul. 8, 2020, as downloaded from https://www.inspiremd.com/en/wp-content/uploads/InspireMD-Investor-Deck-Revised-July-8-2020_compressed.pdf. [cited by applicant]
U.S. Appl. No. 17/576,953 Office Action dated Jul. 20, 2023. [cited by applicant]
U.S. Appl. No. 18/261,673 Office Action dated Feb. 1, 2024. [cited by applicant]
CN Application # 2022800098002 Office Action dated Feb. 23, 2024. [cited by applicant]
JP Applicaton # 2023549856 Office Action dated Mar. 14, 2024. [cited by applicant]
EP Application # 22739245.3 Search Report dated Apr. 9, 2024. [cited by applicant]
CN Application # 2022800089963 Office Action dated Apr. 10, 2024. [cited by applicant]
EP Application # 22774473.7 Search Report dated Jun. 6, 2024. [cited by applicant]
JP Application # 2023542563 Office Action dated Nov. 21, 2023. [cited by applicant]
International Application PCT/IB2023/057821 Search report dated Dec. 31, 2023. [cited by applicant]
Malas et al., “Transcarotid Artery Revascularization versus Transfemoral Carotid Artery Stenting in the Society for Vascular Surgery Vascular Quality Initiative,” Journal of Vascular Surgery, vol. 69, No. 1, pp. 92-103,… [cited by applicant]
Sultan et al., “Endovascular Management of Saccular Extracranial Internal Carotid Artery Aneurysm using Transcervical Carotid Approach and Flow Reversal,” Journal of Vascular Surgery Cases and Innovative Techiques, vol.… [cited by applicant]
Malas et al., “Analysis of the Roadster Pivotal and Extended-access Cohorts Shows Excellent 1-Year Durability of Transcarotid Stenting with Dynamic Flow Reversal,” Journal of Vascular Surgery, vol. 69, No. 6, pp. 1786-1… [cited by applicant]
Elcam Medical, “Y-Click,” Product Information, pp. 1-2, Mar. 2024. [cited by applicant]
“International Standard, ISO 80369-7: Small-bore Connectors for Liquids and Gases in Healthcare Applications—Part 7: Connectors for Intravascular or Hypodermic Applications,” First Edition, pp. iv-11, Oct. 15, 2016. [cited by applicant]
U.S. Appl. No. 18/491,834 Office Action dated Jan. 24, 2025. [cited by applicant]
Final Office Action, U.S. Appl. No. 18,491,834 dated May 14, 2025. [cited by applicant]
Non Final Office Action, U.S. Appl. No. 18,491,834, dated Jan. 24, 2025. [cited by applicant]
Japanese Office Action # 2024-179671, dated Sep. 4, 2025. [cited by applicant]
Japan Patent Office, Office Action, Application No. 2024-026477, dated Apr. 28, 2025. [cited by applicant]
Japan Patent Office, Office Action, Application No. 2024-026477, dated Aug. 4, 2025. [cited by applicant]
World Intellectual Property Organization (WIPO) / Israel Patent Office (ISA/IL), International Search Report and Written Opinion, PCT/IL2025/050040, dated Apr. 30, 2025. [cited by applicant]
Non-Final Office Action, U.S. Appl. No. 18/571,442, dated Apr. 6, 2026. [cited by applicant]
Notice of Allowance, U.S. Appl. No. 14/227,585 dated Apr. 14, 2026. [cited by applicant]
Notice of Appeal from the Examiner, U.S. Appl. No. 17/773,206, dated Mar. 26, 2026. [cited by applicant]
Notice of Panel Decision from Pre-Appeal Brief Review, U.S. Appl. No. 17/773,206, dated Apr. 27, 2026. [cited by applicant]